Enovis (ENOV)
NYSEHealth CareMedical - DevicesSnapshot 2026-11-04
$28.62+17.20%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · ENOV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenues | 2,306.4 | 2,248.0 | 2,107.6 | 1,707.2 | 1,563.1 | 1,426.2 | 1,120.7 | 3,327.5 | 3,300.2 | 3,185.8 | 3,434.4 | 4,624.5 | 4,207.2 | 3,913.9 | 693.4 |
| Total Revenues | — | — | — | — | — | — | — | — | 3,300.2 | 3,185.8 | 3,434.4 | 4,624.5 | 4,207.2 | 3,913.9 | 693.4 |
| Cost of Revenues | 892.4 | 902.8 | 926.9 | 716.4 | 693.7 | 648.5 | 517.1 | 1,926.4 | 1,265.7 | 2,193.4 | 2,362.7 | 3,145.6 | 2,901.0 | 2,761.7 | 453.3 |
| Gross Profit | 1,414.0 | 1,345.3 | 1,180.8 | 990.8 | 869.4 | 777.7 | 603.6 | 1,401.1 | 671.6 | 992.4 | 1,071.7 | 1,478.8 | 1,306.2 | 1,152.1 | 240.1 |
| Operating Expenses & Income | |||||||||||||||
| Selling, General & Admin | 1,076.4 | 1,070.2 | 1,027.4 | 830.3 | 772.9 | 665.8 | 515.5 | 1,132.1 | 500.6 | 696.8 | 748.3 | 1,011.2 | 864.3 | 908.4 | 162.8 |
| R&D Expenses | 125.9 | 120.3 | 91.3 | 75.3 | 60.8 | 49.1 | 34.3 | — | — | — | — | — | — | — | 5.7 |
| Operating Income | (474.9) | (1,124.2) | (775.7) | (65.7) | (71.2) | (62.8) | (66.2) | 203.6 | 135.6 | 236.8 | 265.6 | 409.6 | 406.4 | 140.0 | 25.9 |
| Earnings from Continuing Operations | |||||||||||||||
| Interest Expense | 32.3 | 34.8 | 57.1 | 19.7 | 24.1 | 29.1 | 52.8 | 119.5 | 40.1 | 30.3 | 47.5 | 51.3 | 103.6 | 91.6 | 5.9 |
| Asset Writedown | — | — | — | — | — | — | 1.6 | 0.0 | 183.8 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (501.9) | (1,159.4) | (822.9) | (67.1) | (2.1) | (121.8) | 58.0 | 50.5 | 48.6 | 206.5 | 218.1 | 358.2 | 302.8 | 48.4 | 20.0 |
| Income Tax Expense | 25.1 | 22.3 | 4.5 | (13.3) | 36.1 | (19.5) | (44.6) | 31.6 | 2.5 | 51.8 | 41.2 | (62.0) | 93.7 | 90.7 | 15.4 |
| Net Income | |||||||||||||||
| Minority Interest | — | — | — | — | — | 4.6 | 3.1 | 10.5 | 18.4 | 17.1 | 19.4 | 28.2 | 30.5 | 22.1 | — |
| Net Income | (527.4) | (1,184.4) | (825.5) | (33.3) | (13.3) | 71.7 | 42.6 | (527.6) | 151.1 | 128.1 | 167.7 | 392.1 | 178.6 | (64.4) | 4.6 |
| Per Share | |||||||||||||||
| Basic EPS | (9.14) | (20.75) | (14.93) | (0.61) | (0.25) | 1.40 | 0.93 | (3.89) | 1.23 | 1.04 | 1.35 | 3.06 | 1.56 | (0.92) | — |
| Diluted EPS | (9.02) | (20.75) | (14.93) | (0.61) | (0.25) | 1.40 | 0.93 | (3.89) | 1.22 | 1.04 | 1.34 | 3.02 | 1.54 | (0.92) | — |
| Revenue per Share | 39.43 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 57.7 | 57.1 | 55.3 | 54.5 | 54.1 | 51.1 | 45.6 | 135.7 | 123.2 | 122.9 | 124.1 | 121.1 | 99.2 | 91.1 | — |
| Diluted Weighted Avg Shares | 58.5 | 57.1 | 55.3 | 54.5 | 54.1 | 51.1 | 45.6 | 136.7 | 124.0 | 123.2 | 124.9 | 122.7 | 100.4 | 91.1 | — |
| Supplemental | |||||||||||||||
| EBITDA | — | (829.9) | (490.9) | 151.4 | 148.5 | 200.1 | 180.0 | 439.6 | 267.8 | 365.7 | 402.7 | 584.3 | 525.7 | 323.4 | — |
| EBIT | (474.9) | (1,124.2) | (775.7) | (65.7) | (71.2) | (62.8) | (66.2) | 203.6 | 135.6 | 236.8 | 265.6 | 409.6 | 406.4 | 140.0 | 25.9 |
| Effective Tax Rate | -5.0% | — | — | 19.8% | -1745.8% | 16.0% | -76.8% | 62.6% | 5.1% | 25.1% | 18.9% | -17.3% | 30.9% | 187.3% | 77.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.